請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/64268
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 徐立中 | |
dc.contributor.author | Shu-Wei Hsu | en |
dc.contributor.author | 許書維 | zh_TW |
dc.date.accessioned | 2021-06-16T17:37:51Z | - |
dc.date.available | 2017-09-18 | |
dc.date.copyright | 2012-09-18 | |
dc.date.issued | 2012 | |
dc.date.submitted | 2012-08-15 | |
dc.identifier.citation | Martinon, F., Burns, K. & Tschopp, J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Molecular cell 10, 417-443 (2002).
2 Fantuzzi, G. & Dinarello, C. Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1). Journal of clinical immunology 19, 1-12 (1999). 3 Lamkanfi, M. Emerging inflammasome effector mechanisms. Nature reviews. Immunology 11, 213-233, doi:10.1038 (2011). 4 Boyden, E. & Dietrich, W. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nature genetics 38, 240-244, doi:10.1038 (2006). 5 Faustin, B. et al. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Molecular cell 25, 713-737, doi:10.1016 (2007). 6 Schroder, K., Zhou, R. & Tschopp, J. The NLRP3 inflammasome: a sensor for metabolic danger? Science (New York, N.Y.) 327, 296-596, doi:10.1126 (2010). 7 Chen, G., Liu, M., Wang, F., Bertin, J. & Nunez, G. A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. Journal of immunology (Baltimore, Md. : 1950) 186, 7187-7281, doi:10.4049 (2011). 8 Elinav, E. et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145, 745-802, doi:10.1016 (2011). 9 Grenier, J. et al. Functional screening of five PYPAF family members identifies PYPAF5 as a novel regulator of NF-kappaB and caspase-1. FEBS letters 530, 73-81 (2002). 10 Khare, S. et al. An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages. Immunity 36, 464-540, doi:10.1016 (2012). 11 Zhao, Y. et al. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 477, 596-1196, doi:10.1038 (2011). 12 Fernandes-Alnemri, T. et al. The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nature immunology 11, 385-478, doi:10.1038 (2010). 13 Hornung, V. et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458, 514-522, doi:10.1038 (2009). 14 Unterholzner, L. et al. IFI16 is an innate immune sensor for intracellular DNA. Nature immunology 11, 997-2001, doi:10.1038 (2010). 15 Fernandes-Alnemri, T., Yu, J.-W., Datta, P., Wu, J. & Alnemri, E. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458, 509-522, doi:10.1038 (2009). 16 Wang, S. et al. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 92, 501-510 (1998). 17 Pierini, R. et al. AIM2/ASC triggers caspase-8-dependent apoptosis in Francisella-infected caspase-1-deficient macrophages. Cell death and differentiation, doi:10.1038 (2012). 18 Lamkanfi, M. et al. Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. Journal of immunology (Baltimore, Md. : 1950) 185, 4385-4477, doi:10.4049 (2010). 19 Duprez, L., Wirawan, E., Vanden Berghe, T. & Vandenabeele, P. Major cell death pathways at a glance. Microbes and infection / Institut Pasteur 11, 1050-1112, doi:10.1016 (2009). 20 van Zoelen, M. et al. Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo. Shock (Augusta, Ga.) 31, 280-284, doi:10.1097 (2009). 21 Broz, P., von Moltke, J., Jones, J., Vance, R. & Monack, D. Differential requirement for Caspase-1 autoproteolysis in pathogen-induced cell death and cytokine processing. Cell host & microbe 8, 471-554, doi:10.1016 (2010). 22 Katagiri, N., Shobuike, T., Chang, B., Kukita, A. & Miyamoto, H. The human apoptosis inhibitor NAIP induces pyroptosis in macrophages infected with Legionella pneumophila. Microbes and infection / Institut Pasteur, doi:10.1016 (2012). 23 Gurcel, L., Abrami, L., Girardin, S., Tschopp, J. & van der Goot, F. Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 126, 1135-1180, doi:10.1016 (2006). 24 Dunne, A. Inflammasome activation: from inflammatory disease to infection. Biochemical Society transactions 39, 669-742, doi:10.1042/bst0390669 (2011). 25 Strowig, T., Henao-Mejia, J., Elinav, E. & Flavell, R. Inflammasomes in health and disease. Nature 481, 278-364, doi:10.1038 (2012). 26 Schroder, K. & Tschopp, J. The inflammasomes. Cell 140, 821-853, doi:10.1016 (2010). 27 Perkins, N. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nature reviews. Molecular cell biology 8, 49-111, doi:10.1038 (2007). 28 Hayden, M. & Ghosh, S. Signaling to NF-kappaB. Genes & development 18, 2195-2419, doi:10.1101 (2004). 29 Bonizzi, G. & Karin, M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends in immunology 25, 280-288, doi:10.1016 (2004). 30 Bauernfeind, F. et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. Journal of immunology (Baltimore, Md. : 1950) 183, 787-878, doi:10.4049 (2009). 31 Kahlenberg, J., Lundberg, K., Kertesy, S., Qu, Y. & Dubyak, G. Potentiation of caspase-1 activation by the P2X7 receptor is dependent on TLR signals and requires NF-kappaB-driven protein synthesis. Journal of immunology (Baltimore, Md. : 1950) 175, 7611-7633 (2005). 32 Greten, F. et al. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 130, 918-949, doi:10.1016 (2007). 33 Sarkar, A. et al. ASC directs NF-kappaB activation by regulating receptor interacting protein-2 (RIP2) caspase-1 interactions. Journal of immunology (Baltimore, Md. : 1950) 176, 4979-5065 (2006). 34 Lee, J., Cochran, B., Lobov, S. & Ranson, M. Forty years later and the role of plasminogen activator inhibitor type 2/SERPINB2 is still an enigma. Seminars in thrombosis and hemostasis 37, 395-802, doi:10.1055 (2011). 35 Yu, H., Maurer, F. & Medcalf, R. L. Plasminogen activator inhibitor type 2: a regulator of monocyte proliferation and differentiation. Blood 99, 2810-2818 (2002). 36 Medcalf, R. L. & Stasinopoulos, S. J. The undecided serpin. The ins and outs of plasminogen activator inhibitor type 2. Febs J 272, 4858-4867 (2005). 37 Costelloe, E., Stacey, K., Antalis, T. & Hume, D. Regulation of the plasminogen activator inhibitor-2 (PAI-2) gene in murine macrophages. Demonstration of a novel pattern of responsiveness to bacterial endotoxin. Journal of leukocyte biology 66, 172-254 (1999). 38 Croucher, D. R., Saunders, D. N., Lobov, S. & Ranson, M. Revisiting the biological roles of PAI2 (SERPINB2) in cancer. Nat Rev Cancer 8, 535-545, doi: 10.1038 (2008). 39 Park, J. et al. Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis--CREB and NF-kappaB as key regulators. Immunity 23, 319-348, doi:10.1016 (2005). 40 Greten, F. R. et al. NF-kappaB Is a Negative Regulator of IL-1beta Secretion as Revealed by Genetic and Pharmacological Inhibition of IKKbeta. Cell 130, 918-931 (2007). 41 Solem, A., Zingler, N. & Pyle, A. A DEAD protein that activates intron self-splicing without unwinding RNA. Molecular cell 24, 611-618, doi:10.1016 (2006). 42 Iost, I. & Dreyfus, M. DEAD-box RNA helicases in Escherichia coli. Nucleic acids research 34, 4189-4286, doi:10.1093 (2006). 43 Linder, P. Dead-box proteins: a family affair--active and passive players in RNP-remodeling. Nucleic acids research 34, 4168-4248, doi:10.1093 (2006). 44 Shajani, Z., Sykes, M. & Williamson, J. Assembly of bacterial ribosomes. Annual review of biochemistry 80, 501-527, doi:10.1146 (2011). 45 Weirich, C. et al. Activation of the DExD/H-box protein Dbp5 by the nuclear-pore protein Gle1 and its coactivator InsP6 is required for mRNA export. Nature cell biology 8, 668-744, doi:10.1038 (2006). 46 Tran, E., Zhou, Y., Corbett, A. & Wente, S. The DEAD-box protein Dbp5 controls mRNA export by triggering specific RNA:protein remodeling events. Molecular cell 28, 850-859, doi:10.1016 (2007). 47 Li, J. & Li, W. A novel function of Drosophila eIF4A as a negative regulator of Dpp/BMP signalling that mediates SMAD degradation. Nature cell biology 8, 1407-1421, doi:10.1038 (2006). 48 Watanabe, M. et al. A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA. The EMBO journal 20, 1341-1393, doi:10.1093 (2001). 49 Linder, P. & Jankowsky, E. From unwinding to clamping - the DEAD box RNA helicase family. Nature reviews. Molecular cell biology 12, 505-521, doi:10.1038 (2011). 50 Tanner, N., Cordin, O., Banroques, J., Doere, M. & Linder, P. The Q motif: a newly identified motif in DEAD box helicases may regulate ATP binding and hydrolysis. Molecular cell 11, 127-165 (2003). 51 Jarmoskaite, I. & Russell, R. DEAD-box proteins as RNA helicases and chaperones. Wiley interdisciplinary reviews. RNA 2, 135-187, doi:10.1002 (2011). 52 Yang, Q., Del Campo, M., Lambowitz, A. & Jankowsky, E. DEAD-box proteins unwind duplexes by local strand separation. Molecular cell 28, 253-316, doi:10.1016 (2007). 53 Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nature immunology 5, 730-737, doi:10.1038 (2004). 54 Kawai, T. et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nature immunology 6, 981-989, doi:10.1038 (2005). 55 Andrejeva, J. et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proceedings of the National Academy of Sciences of the United States of America 101, 17264-17273, doi:10.1073 (2004). 56 Zhang, Z. et al. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nature immunology 12, 959-1024, doi:10.1038 (2011). 57 Ishaq, M. et al. The DEAD-box RNA helicase DDX1 interacts with RelA and enhances nuclear factor kappaB-mediated transcription. Journal of cellular biochemistry 106, 296-601, doi:10.1002 (2009). 58 Pyle, A. RNA helicases and remodeling proteins. Current opinion in chemical biology 15, 636-678, doi:10.1016 (2011). 59 Chuang, Y.-T. et al. Tumor suppressor death-associated protein kinase is required for full IL-1β production. Blood 117, 960-1030, doi:10.1182 (2011). 60 Rathinam, V., Vanaja, S. & Fitzgerald, K. Regulation of inflammasome signaling. Nature immunology 13, 333-335, doi:10.1038 (2012). | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/64268 | - |
dc.description.abstract | 近幾年,發炎體(the inflammasomes)這種新興蛋白質複合體在免疫學界中迅速竄起,被證實其是大多數多細胞生物體內用以對抗病原體的一環。發炎體主要牽涉到先天免疫中發炎反應啟動的過程,其具有將第一型半胱天冬酶(caspase-1)活化並間接催化第一型介白素β (IL-1β)與第十八型介白素(IL-18)熟成的能力,以協助宿主對抗病原體。但發炎體究竟是如何被調控的至今尚未明瞭。
過去研究中,指出第二型纖溶酶原激活物抑制酶(PAI-2)在受LPS刺激的巨噬細胞中能夠抑制第一型介白素β的熟成,同時能減少刺激後Annexin V的訊號強度,但第二型纖溶酶原激活物抑制酶是如何做到這點的目前並不清楚。我們實驗室進行了酵母雙雜交實驗發現一核醣核酸解旋脢為第二型纖溶酶原激活物抑制酶的結合蛋白。本篇研究的目標即為透過深入研究兩者關係來進一步瞭解第二型纖溶酶原激活物抑制酶是如何調節第一型介白素β的熟成。 此次研究中,我們在人類胚腎細胞株HEK293T內證實該核醣核酸解旋脢是第二型纖溶酶原激活物抑制酶的結合蛋白。當我們進一步利用RNA干擾技術(RNA interference)抑制該核醣核酸解旋脢的基因表現後,不管是在以分化的人類巨噬細胞THP-1細胞株或是小鼠骨髓細胞分化而成的巨噬細胞(BMDM)中都能大幅提高成熟型第一型半胱天冬酶(mature caspase-1) 活性以及成熟型第一型介白素β (mature IL-1β)的釋放,卻不影響上游前第一型介白素β核醣核酸 (pro-IL-1β mRNA)以及前第一型介白素β蛋白質(pro-IL-1β)的數量,這指出該核醣核酸解旋脢可能涉入發炎體將第一型介白素從前型轉為成熟型的熟成過程。反之,當在HEK293T細胞過度表達該核醣核酸解旋脢時可以抑制重組NLRP3發炎體將前第一型介白素β轉化為成熟型的效率,證實該核醣核酸解旋脢能夠負調控發炎體的活性。 | zh_TW |
dc.description.abstract | Innate immunity is an evolutionarily conserved defense mechanism against infection. Upon infection, the innate immune response is immediately initiated to clear pathogens and repair damage tissues. Recently, a novel system named the inflammasome, a multiple protein complexes modulating caspase-1 activity, has been described. Activation of the inflammasome results in the cleavage of precursors of pro-inflammatory cytokines IL-1β and IL-18, into their bioactive forms. The inflammasome has been shown to play a crucial role in host defense against bacterial and viral infection in vivo. A growing body of evidence, however, demonstrated that dysregulation of the inflammasome activity has been associated with a variety of human diseases including auto-inflammatory and metabolic diseases. Thus, activation of the inflammasome must be tightly controlled, but its positive and negative regulation remains largely unknown.
Previous studies demonstrated that the overexpression of PAI-2, a transcriptional target gene of NF-κB and p38, suppressed IL-1β production is still unknown. Our lab recently screened PAI-2-interacting proteins using the yeast two-hybrid system and identified several candidate proteins. Amongst these proteins, one of which is one member of DEAD-box protein family. DEAD-box protein family including RIG-I, MDA5, and DDX41 which contribute to innate immune responses against viral infection. This protein family is known for its abilities in RNA metabolism and RNA-protein crosstalk; yet, the exact function of the DEAD-box protein we screened has not been proposed to date. Thus, we aim to study the role of this DEAD-box protein in LPS-induced IL-1β production. In this study, we found that ablation of this DEAD-box protein in differentiated THP-1 macrophages and bone marrow derived macrophages (BMDMs) largely enhance caspase-1 activation and mature IL-1β production upon LPS challenge. Besides, in response to LPS treatment, no significant alteration on pro-IL-1β expression was observed in this DEAD-box protein-ablated cells compared to wild type cells. Overexpression of this DEAD-box protein suppressed mature IL-1β production in the reconstitution of NLRP3 inflammasome in HEK293T cells. Our results strongly suggest that this DEAD-box protein may act as a negative regulator of Inflammasome activation. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T17:37:51Z (GMT). No. of bitstreams: 1 ntu-101-R99448014-1.pdf: 2821978 bytes, checksum: 3048c0b05adbcae2846a175607e914f3 (MD5) Previous issue date: 2012 | en |
dc.description.tableofcontents | 摘要 1
Abstract 3 Contents 5 Introduction 7 The Inflammasomes 7 Classes of the inflammasomes 7 Structure of the inflammasomes 8 Pyroptosis 9 Regulation of the inflammasomes 11 NF-κB signaling 13 Canonical pathway 14 Non-canonical pathway 14 NF-κB signaling and the inflammasomes 15 PAI-2 16 Overview of the DEAD RNA Helicase family 17 The helicase core 18 The DEAD-box proteins and the immune system 19 DDX27 19 Specific aim 20 Materials and Methods 22 Reagents 22 Plasmids 23 Preparation of pseudotyped lentiviruses 24 Cell culture and transfection 25 Preparation of Bone marrow derived macrophage (BMDM) 26 Total RNA extraction and Quantitative Real-Time RT-PCR (RT-QPCR) 27 Preparation of whole cell lysate 28 Measurement of secreted cytokines and caspase-1 29 Preparation of nuclear and cytosolic extracts 29 Immunoblotting 30 Immunoprecipitation 31 Immunofluorescence staining 31 Reconstitution of NLRP3 inflammasome in HEK293T cells 32 Result 34 1. DDX27 expression is decreased in LPS-induced macrophages 34 2. Knockdown of DDX27 enhanced the activation of the inflammasome and IL-1β production in THP-1 macrophages upon LPS treatment 35 3. Ablation of DDX27 in THP-1 macrophages did not change the expression of LPS-induced genes 36 4. Knockdown of DDX27 induced IL-1β production in BMDMs after LPS stimulation. 38 5. DDX27 inhibited mature IL-1β production in HEK293T cells reconstituted with the NLRP3 inflammasome. 39 6. DDX27 associated with PAI-2 when overexpressed in HEK293T cells. 40 Discussion 42 Figures 48 Figure 1 48 Figure 2 49 Figure 3 50 Figure 4 52 Figure 5 53 Figure 6 55 Figure 7 56 Figure 8 57 Figure 9 59 Appendices 61 Appendix A 61 Appendix B 63 Appendix C 64 Reference 65 | |
dc.language.iso | en | |
dc.title | 一個新穎的核醣核酸解旋酶於發炎反應中的角色 | zh_TW |
dc.title | The role of a novel DEAD-box protein in LPS-induced inflammation | en |
dc.type | Thesis | |
dc.date.schoolyear | 100-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 林琬琬,繆希椿 | |
dc.subject.keyword | 發炎反應,核醣核酸解旋酶,第一型介白素β, | zh_TW |
dc.subject.keyword | inflammation,RNA helicase,IL-1β, | en |
dc.relation.page | 70 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2012-08-15 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 分子醫學研究所 | zh_TW |
顯示於系所單位: | 分子醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-101-1.pdf 目前未授權公開取用 | 2.76 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。